Medirom Healthcare Technologies Inc. (NASDAQ:MRM – Get Free Report) was the target of a significant increase in short interest in the month of October. As of October 15th, there was short interest totaling 29,941 shares, an increase of 977.4% from the September 30th total of 2,779 shares. Currently, 0.2% of the company’s stock are short sold. Based on an average daily volume of 656,382 shares, the days-to-cover ratio is presently 0.0 days.
Wall Street Analysts Forecast Growth
Separately, Weiss Ratings reaffirmed a “sell (d)” rating on shares of Medirom Healthcare Technologies in a research report on Tuesday, August 25th. One analyst has rated the stock with a Sell rating. According to MarketBeat.com, Medirom Healthcare Technologies presently has a consensus rating of “Sell”.
View Our Latest Analysis on MRM
Medirom Healthcare Technologies Trading Down 1.4%
Shares of NASDAQ MRM traded down $0.01 during trading hours on Tuesday, hitting $0.35. The stock had a trading volume of 5,308 shares, compared to its average volume of 270,120. The firm’s 50-day moving average price is $0.73 and its two-hundred day moving average price is $1.09. Medirom Healthcare Technologies has a 52 week low of $0.24 and a 52 week high of $2.73.
About Medirom Healthcare Technologies
Medirom Healthcare Technologies Inc is a Japan-based healthcare and wellness company that provides services designed to support relaxation, physical conditioning and preventative health. The company operates through a network of wellness salons and related healthcare businesses, serving consumers primarily in Japan.
Its principal salon brand, Re.Ra.Ku, offers services such as body care, stretching, reflexology and other relaxation treatments. Medirom serves customers through company-operated and franchised locations, with its services focused on helping clients manage fatigue, improve flexibility and maintain general physical well-being.
In addition to its salon operations, Medirom has pursued digital healthcare and wearable technology initiatives, including products intended to monitor health and wellness information.
Further Reading
- Five stocks we like better than Medirom Healthcare Technologies
- Whirlpool’s Stock Collapse Raises a Bigger Question About Its Recovery Potential
- Analysts Turn Bullish on Meta Platforms Despite Post-Earnings Fall
- Approaching Earnings Season, Are Pure Play Quantum Stocks Still a Good Bet?
- Lockheed Martin’s F-35 Deal Could Change How Wall Street Values the Stock
Receive News & Ratings for Medirom Healthcare Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medirom Healthcare Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
